U.S. Health Dept. Layoffs Impact Neuralink Oversight

In an unexpected move, the U.S. Department of Health and Human Services has laid off about 5,200 employees, including those linked to Neuralink's oversight. This decision raises concerns over its potential impact on the speed and safety of pharmaceutical reviews. Despite controversy, anonymous sources reveal these employees were not targeted, aiming to cut government spending. Stay informed on this developing story, tech innovations from Elon Musk's xAI, and more. Don't forget to like and subscribe for more updates from Global Chatters!

Видео U.S. Health Dept. Layoffs Impact Neuralink Oversight канала Global Chatters